JCO Article Insights: TROPION-Lung01 Dato-DXd in NSCLC

<p class="MsoNormal"><span style= "font-size: 12pt; font-family: arial, helvetica, sans-serif;">In this JCO Article Insights episode, Ece Cali summarizes findings from the JCO article, "<a href= "https://ascopubs.org/doi/10.1200/JCO-24-01544">Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study.</a>"</span></p> <p class="MsoNormal"><span style= "text-decoration: underline; font-size: 12pt; font-family: arial, helvetica, sans-serif;"> <strong>TRANSCRIPT</strong></span></p> <p class="MsoNormal"><span style= "font-size: 12pt; font-family: arial, helvetica, sans-serif;"><strong style="mso-bidi-font-weight: normal;"> <span lang="EN" xml:lang="EN">Ece Cali:</span></strong> <span lang= "EN" xml:lang="EN">Hello and welcome to the <em style= "mso-bidi-font-style: normal;"><a href= "https://ascopubs.org/journal/jco/podcast">JCO Article Insights</a>.</em> I'm your host Ece Cali a...